Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 17.6.2022Zentiva, k.s. (ZNT-1)2509DZetovar 10 mg/20 mg tablety (tbl 90x10 mg/20 mg (blis.OPA/Al/PVC))21.6.2022O
 17.6.2022Zentiva, k.s. (ZNT-1)3065BTorvacard Novum 40 mg (tbl flm 90x40 mg (blis.OPA/Al/PVC/Al))17.6.2022O
 17.6.2022Zentiva, k.s. (ZNT-1)81777Valzap 160 mg (tbl flm 84x160 mg (blis.PVC/PE/PVDC/Al))21.6.2022O
 17.6.2022Zentiva, k.s. (ZNT-1)99600ZODAC (tbl flm 90x10 mg (blis.PVC/PVDC/Al))21.6.2022O
 17.6.2022XANTIS PHARMA LIMITED (XNT-1)1800ADesloratadin Xantis 5 mg (tbl 10x5 mg (blis.OPA/Al/PVC/Al))16.6.2022O
 17.6.2022Mundipharma Gesellschaft m.b.H. (MUP-A-2)92310DHC Continus 60 mg (tbl mod 60x60 mg (blis.PVC/Al))20.6.2022O
 17.6.2022Mundipharma Gesellschaft m.b.H. (MUP-A-2)94312MST Continus 100 mg (tbl mod 60x100 mg (blis.PVC/PVDC/Al))20.6.2022O
 17.6.2022Mundipharma Gesellschaft m.b.H. (MUP-A-2)94311MST Continus 60 mg (tbl mod 60x60 mg (Al/PVDC/PVC))20.6.2022O
 16.6.2022Vipharm S.A. (VIH-PL-1)7562CNaxalgan 150 mg (cps dur 60x150 mg (blis.Al/PVC/PE/PVDC))22.6.2022R
 16.6.2022Vipharm S.A. (VIH-PL-1)7556CNaxalgan 75 mg (cps dur 60x75 mg (blis.Al/PVC/PE/PVDC))22.6.2022R
 16.6.2022Vipharm S.A. (VIH-PL-1)47803Donesyn 10 mg (tbl flm 98x10 mg (blis.PVC/Al))27.6.2022R
 16.6.2022Berlin-Chemie AG (BCE)51621Bromhexin 8 Berlin-Chemie (tbl obd 25x8 mg (blis.PVC/Al))16.6.2022R
 16.6.2022A. Menarini Industrie Farmaceutiche Riunite s.r.l. (MEN-2)83106Lioton gel 100 000 (gel 1x30 g (tuba Al))16.6.2022R
 16.6.2022bene-Arzneimittel GmbH (BNZ)1887DTalvosilen plus 1 000 mg/60 mg tablety (tbl 20x1000 mg/60 mg (blis.PVC/Al))16.6.2022R
 15.6.2022Instituto Grifols, S.A. (GFO)45080Flebogamma DIF 50 mg/ml infúzny roztok (sol inf 1x10 ml/0,5 g (liek.skl.))15.6.2022R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To